Surgical Sutures Market Size to Record 6% CAGR over 2023-2030; Launch of Technologically Advanced Products to Accelerate Market Expansion

The global surgical sutures market size was valued at USD 5.03 billion in 2022 and is predicted to reach USD 5.33 billion in 2023. The market is anticipated to touch USD 8.04 billion by 2030, recording a CAGR of 6% over 2023-2030.

Fortune Business Insights™ presents this information in its latest report titled “Surgical Sutures Market Size, Share & COVID-19 Impact Analysis, By Product Type (Absorbable and Non-absorbable), By Form (Natural and Synthetic), By Application (Gynecology, Cardiology, Orthopedics, General Surgery, and Others), By End-user (Hospitals & ASCs and Specialty Clinics), and Regional Forecast, 2023-2030”.

Surgical sutures have always been in high demand in the healthcare sector as the number of surgical procedures is increasing every year. These sutures are majorly used to close open wounds during and after a surgery to speed up the healing and recovery time. Many companies are introducing technologically advanced versions of these products to enhance patient care and wound management. This factor is expected to accelerate the surgical sutures market growth.

COVID-19 Decreased Product Demand due to Decline in Elective Surgeries

The COVID-19 pandemic had an adverse effect on the functioning of the market as clinics and surgical centers increased their focus on treating patients that required urgent surgery. Also, all the vital healthcare resources were diverted toward taking care of COVID-19-infected patients. These factors forced surgeons to postpone their elective or non-urgent surgeries, thereby negatively impacting the market growth.

GTCR and Corza Health Merged TachoSil and Surgical Specialties to Create a New Company

GTCR, a private equity firm, in partnership with Corza Health, announced that it acquired and merged Surgical Specialties Corporation and TachoSil to create a new company named Corza Medical. Surgical Specialties Corporation is a medical technology firm that focuses on high-performance ophthalmic knives and surgical sutures.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/surgical-sutures-market-100660

Launch of Technologically Advanced Products to Accelerate Market Expansion

The healthcare industry is becoming increasingly familiar with innovative surgical procedures, which has encouraged leading market players to increase their Research & Development (R&D) efforts. This has helped them launch innovative products in the market. Moreover, the growing launch of new and automated sutures that come with improved features is another factor that has improved the product demand among surgeons across the world.

Key Market Players to Introduce Technologically Advanced Products to Maintain Dominance

The global market is highly competitive and dominated by leading companies, such as B. Braun Melsungen, Medtronic, and Ethicon U.S., as they are known for having a vast range of medical products and solutions. They are now focusing on introducing technologically advanced products to help surgeons carry out complex surgical procedures. They are also trying to expand their production capacities to cater to the growing demand for futuristic medical devices. The abovementioned factors are expected to help these companies dominate the global market.

Notable Industry Development:

• September 2022 - Mesh Suture, Inc. revealed that it had received the U.S. FDA’s 510(k) clearance for its non-absorbable polypropylene mesh suture called DURAMESH.

List of Key Companies Profiled in the Report:

• B. Braun SE (Germany)


• Johnson & Johnson Services, Inc. (U.S.)


• Smith & Nephew (U.K.)


• Medtronic (Ireland)


• Coloplast A/S (Denmark)


• Apollo Endosurgery, Inc. (U.S.)


• Boston Scientific Corporation (U.S.)


• DemeTECH Corporation (U.S.)


• TEPHA INC. (U.S.)


• Internacional Farmacéutica (Mexico)


• Kono Seisakusho Co., Ltd. (Japan)


• CONMED Corporation (U.S.)

Further Report Findings:

• North America accounted for the biggest surgical sutures market share in 2022 and is anticipated to maintain its dominance during the forecast timeframe. The region is witnessing a worrying growth in the incidence of chronic diseases. The region’s geriatric population is on the rise as well. These factors will increase the number of surgical procedures, which in turn, will boost the product adoption.


• The market in Asia Pacific is also predicted to record a notable CAGR in the coming years due to various factors. These factors include growing awareness of innovative surgical procedures, rising prevalence of gynecological & cardiovascular ailments, and growing focus of key market players in emerging countries on introducing innovative surgical sutures.


• The absorbable suture segment generated higher revenue in 2022 and may dominate the market during the forecast period. The segment’s dominance arises from the growing awareness regarding the benefits of using these sutures. These advantages include effectiveness in suturing delicate & deep wounds, high support to closed wounds due to great tensile strength, and lesser healing & recovery time.

Table of Segmentation